Nawrocki ST - Search Results

1

A Phase II Study of Pelareorep (REOLYSIN^®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma.

Mahalingam D, Goel S, Aparo S, Patel Arora S, Noronha N, Tran H, Chakrabarty R, Selvaggi G, Gutierrez A, Coffey M, Nawrocki ST, Nuovo G, Mita MM. Mahalingam D, et al. Among authors: nawrocki st. Cancers (Basel). 2018 May 25;10(6):160. doi: 10.3390/cancers10060160. Cancers (Basel). 2018. PMID: 29799479 Free PMC article.

2

The Novel Lysosomal Autophagy Inhibitor (ROC-325) Ameliorates Experimental Pulmonary Hypertension.

Bao C, Liang S, Han Y, Yang Z, Liu S, Sun Y, Zheng S, Li Y, Wang T, Gu Y, Wu K, Black SM, Wang J, Nawrocki ST, Carew JS, Yuan JX, Tang H. Bao C, et al. Among authors: nawrocki st. Hypertension. 2023 Jan;80(1):70-83. doi: 10.1161/HYPERTENSIONAHA.122.19397. Epub 2022 Nov 8. Hypertension. 2023. PMID: 36345832

3

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics.

Mita AC, Mita MM, Nawrocki ST, Giles FJ. Mita AC, et al. Among authors: nawrocki st. Clin Cancer Res. 2008 Aug 15;14(16):5000-5. doi: 10.1158/1078-0432.CCR-08-0746. Clin Cancer Res. 2008. PMID: 18698017 Review.

4

Targeting HSP90 for cancer therapy.

Mahalingam D, Swords R, Carew JS, Nawrocki ST, Bhalla K, Giles FJ. Mahalingam D, et al. Among authors: nawrocki st. Br J Cancer. 2009 May 19;100(10):1523-9. doi: 10.1038/sj.bjc.6605066. Epub 2009 Apr 28. Br J Cancer. 2009. PMID: 19401686 Free PMC article. Review.

5

Targeted therapy for advanced non-small cell lung cancers: historical perspective, current practices, and future development.

Mahalingam D, Mita A, Mita MM, Nawrocki ST, Giles FJ. Mahalingam D, et al. Among authors: nawrocki st. Curr Probl Cancer. 2009 Mar-Apr;33(2):73-111. doi: 10.1016/j.currproblcancer.2009.03.001. Curr Probl Cancer. 2009. PMID: 19409299 Review. No abstract available.

6

Emerging drugs in the treatment of pancreatic cancer.

Mahalingam D, Kelly KR, Swords RT, Carew J, Nawrocki ST, Giles FJ. Mahalingam D, et al. Among authors: nawrocki st. Expert Opin Emerg Drugs. 2009 Jun;14(2):311-28. doi: 10.1517/14728210902972502. Expert Opin Emerg Drugs. 2009. PMID: 19466902 Review.

7

Reovirus-based therapy for cancer.

Kelly K, Nawrocki S, Mita A, Coffey M, Giles FJ, Mita M. Kelly K, et al. Expert Opin Biol Ther. 2009 Jul;9(7):817-30. doi: 10.1517/14712590903002039. Expert Opin Biol Ther. 2009. PMID: 19527106 Review.

8

Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation.

Carew JS, Medina EC, Esquivel JA 2nd, Mahalingam D, Swords R, Kelly K, Zhang H, Huang P, Mita AC, Mita MM, Giles FJ, Nawrocki ST. Carew JS, et al. Among authors: nawrocki st. J Cell Mol Med. 2010 Oct;14(10):2448-59. doi: 10.1111/j.1582-4934.2009.00832.x. J Cell Mol Med. 2010. PMID: 19583815 Free PMC article.

9

Vorinostat enhances the activity of temsirolimus in renal cell carcinoma through suppression of survivin levels.

Mahalingam D, Medina EC, Esquivel JA 2nd, Espitia CM, Smith S, Oberheu K, Swords R, Kelly KR, Mita MM, Mita AC, Carew JS, Giles FJ, Nawrocki ST. Mahalingam D, et al. Among authors: nawrocki st. Clin Cancer Res. 2010 Jan 1;16(1):141-53. doi: 10.1158/1078-0432.CCR-09-1385. Epub 2009 Dec 22. Clin Cancer Res. 2010. PMID: 20028765

10

Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia.

Swords RT, Kelly KR, Smith PG, Garnsey JJ, Mahalingam D, Medina E, Oberheu K, Padmanabhan S, O'Dwyer M, Nawrocki ST, Giles FJ, Carew JS. Swords RT, et al. Among authors: nawrocki st. Blood. 2010 May 6;115(18):3796-800. doi: 10.1182/blood-2009-11-254862. Epub 2010 Mar 4. Blood. 2010. PMID: 20203261 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page